GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Santen Pharmaceutical Co Ltd (OTCPK:SNPHY) » Definitions » Shiller PE Ratio

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Shiller PE Ratio : 26.27 (As of May. 11, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Santen Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-11), Santen Pharmaceutical Co's current share price is $10.77. Santen Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was $0.41. Santen Pharmaceutical Co's Shiller PE Ratio for today is 26.27.

The historical rank and industry rank for Santen Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SNPHY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.41   Med: 25.17   Max: 45.65
Current: 25.85

During the past years, Santen Pharmaceutical Co's highest Shiller PE Ratio was 45.65. The lowest was 14.41. And the median was 25.17.

SNPHY's Shiller PE Ratio is ranked better than
52.64% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs SNPHY: 25.85

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.41 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Santen Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Santen Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Santen Pharmaceutical Co Shiller PE Ratio Chart

Santen Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.32 24.40 18.65 19.00 24.07

Santen Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.00 20.02 21.68 21.94 24.07

Competitive Comparison of Santen Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Shiller PE Ratio falls into.



Santen Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Santen Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=10.77/0.41
=26.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Santen Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.002/107.2000*107.2000
=0.002

Current CPI (Mar. 2024) = 107.2000.

Santen Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.096 98.000 0.105
201409 0.128 98.500 0.139
201412 0.152 97.900 0.166
201503 0.135 97.900 0.148
201506 0.147 98.400 0.160
201509 0.723 98.500 0.787
201512 0.123 98.100 0.134
201603 0.074 97.900 0.081
201606 0.167 98.100 0.182
201609 0.123 98.000 0.135
201612 0.098 98.400 0.107
201703 0.099 98.100 0.108
201706 0.199 98.500 0.217
201709 0.138 98.800 0.150
201712 0.262 99.400 0.283
201803 0.183 99.200 0.198
201806 0.153 99.200 0.165
201809 0.164 99.900 0.176
201812 0.196 99.700 0.211
201903 0.190 99.700 0.204
201906 0.148 99.800 0.159
201909 0.157 100.100 0.168
201912 0.164 100.500 0.175
202003 0.077 100.300 0.082
202006 0.144 99.900 0.155
202009 0.180 99.900 0.193
202012 0.173 99.300 0.187
202103 -0.269 99.900 -0.289
202106 0.167 99.500 0.180
202109 0.158 100.100 0.169
202112 0.111 100.100 0.119
202203 0.166 101.100 0.176
202206 0.125 101.800 0.132
202209 -0.527 103.100 -0.548
202212 0.115 104.100 0.118
202303 0.019 104.400 0.020
202306 0.197 105.200 0.201
202309 0.166 106.200 0.168
202312 0.143 106.800 0.144
202403 0.002 107.200 0.002

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Santen Pharmaceutical Co  (OTCPK:SNPHY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Santen Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Santen Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Santen Pharmaceutical Co (Santen Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company reports two primary operating segments: prescription ophthalmic pharmaceuticals and other. The pharmaceuticals segment includes over-the-counter pharmaceuticals, while the other segment includes medical devices. The vast majority of Santen's revenue is derived from its prescription ophthalmic pharmaceuticals segment, which manufactures and distributes prescription and OTC pharmaceuticals. Most of Santen's sales are generated in Japan, followed by other Asian countries.

Santen Pharmaceutical Co (Santen Pharmaceutical Co) Headlines

From GuruFocus

Matthews Japan Fund 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 04-23-2020

Matthews Japan Fund Comments on Santen Pharmaceutical

By Sydnee Gatewood Sydnee Gatewood 04-23-2020